Related references
Note: Only part of the references are listed.Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
Filippo Veglia et al.
NATURE REVIEWS IMMUNOLOGY (2021)
HPMA-based star polymer biomaterials with tuneable structure and biodegradability tailored for advanced drug delivery to solid tumours
Libor Kostka et al.
BIOMATERIALS (2020)
Polymer Cancerostatics Containing Cell-Penetrating Peptides: Internalization Efficacy Depends on Peptide Type and Spacer Length
Eliska Bohmova et al.
PHARMACEUTICS (2020)
Matrix metalloproteinase-9 (MMP-9) and its inhibitors in cancer: A minireview
Subha Mondal et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
The New Era of Cancer Immunotherapy: Targeting Myeloid-Derived Suppressor Cells to Overcome Immune Evasion
Paola De Cicco et al.
FRONTIERS IN IMMUNOLOGY (2020)
Alterations in NO- and PGI2- dependent function in aorta in the orthotopic murine model of metastatic 4T1 breast cancer: relationship with pulmonary endothelial dysfunction and systemic inflammation
E. Buczek et al.
BMC CANCER (2018)
All-Trans Retinoic Acid Enhances Matrix Metalloproteinase 2 Expression and Secretion in Human Myeloid Leukemia THP-1 Cells
Hien Thi Vu et al.
BIOMED RESEARCH INTERNATIONAL (2018)
Discovery of a highly selective chemical inhibitor of matrix metalloproteinase-9 (MMP-9) that allosterically inhibits zymogen activation
Robert H. Scannevin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Star Polymer-Drug Conjugates with pH-Controlled Drug Release and Carrier Degradation
H. Kostkova et al.
JOURNAL OF NANOMATERIALS (2017)
A tumor-targeted polymer theranostics platform for positron emission tomography and fluorescence imaging
Eva Koziolova et al.
NANOSCALE (2017)
Targeted Drug Delivery with Polymers and Magnetic Nanoparticles: Covalent and Noncovalent Approaches, Release Control, and Clinical Studies
Karel Ulbrich et al.
CHEMICAL REVIEWS (2016)
Macromolecular therapeutics
Jiyuan Yang et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Polymer-drug conjugates: Origins, progress to date and future directions
Jindrich Kopecek
ADVANCED DRUG DELIVERY REVIEWS (2013)
HPMA copolymer-doxorubicin conjugates: The effects of molecular weight and architecture on biodistribution and in vivo activity
Tomas Etrych et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Matrix metalloproteinases in tumorigenesis: an evolving paradigm
Hui Hua et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2011)
Pyrone-Based Inhibitors of Metalloproteinase Types 2 and 3 May Work as ConformationSelective Inhibitors
Jacob D. Durrant et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2011)
Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting
Chrisostomi Gialeli et al.
FEBS JOURNAL (2011)
Biodegradable star HPMA polymer-drug conjugates: Biodegradability, distribution and anti-tumor efficacy
Tomas Etrych et al.
JOURNAL OF CONTROLLED RELEASE (2011)
Modes of Action of Microbially-Produced Phytotoxins
Stephen O. Duke et al.
TOXINS (2011)
HPMA copolymers: Origins, early developments, present, and future
Jindrich Kopecek et al.
ADVANCED DRUG DELIVERY REVIEWS (2010)
Polymer therapeutics: Clinical applications and challenges for development Preface
Maria J. Vicent et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
N-(2-hydroxypropyl)methacrylamide-based polymer conjugates with pH-controlled activation of doxorubicin.: I.: New synthesis, physicochemical characterization and preliminary biological evaluation
Tomas Etrych et al.
JOURNAL OF APPLIED POLYMER SCIENCE (2008)
Murine mammary carcinoma 4T1 induces a leukemoid reaction with splenomegaly: Association with tumor-derived growth factors
Sally A. duPre' et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2007)
Human meprin α and β homo-oligomers:: cleavage of basement membrane proteins and sensitivity to metalloprotease inhibitors
MN Kruse et al.
BIOCHEMICAL JOURNAL (2004)
Chemically modified tetracyclines as inhibitors of matrix metalloproteinases
MR Acharya et al.
DRUG RESISTANCE UPDATES (2004)
Human mitochondrial peptide deformylase, a new anticancer target of actinonin-based antibiotics
MD Lee et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
The dawning era of polymer therapeutics
R Duncan
NATURE REVIEWS DRUG DISCOVERY (2003)
Cancer therapy - Matrix metalloproteinase inhibitors and cancer: Trials and tribulations
LM Coussens et al.
SCIENCE (2002)
Water soluble polymers in tumor targeted delivery
J Kopecek et al.
JOURNAL OF CONTROLLED RELEASE (2001)
New HPMA copolymers containing doxorubicin bound via pH-sensitive linkage:: synthesis and preliminary in vitro and in vivo biological properties
T Etrych et al.
JOURNAL OF CONTROLLED RELEASE (2001)
Actinonin, a naturally occurring antibacterial agent, is a potent deformylase inhibitor
DZ Chen et al.
BIOCHEMISTRY (2000)
Share Paper
